Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on March 1, 2007

Stroke. 2007
Published online before print March 1, 2007, doi: 10.1161/01.STR.0000260095.94175.d0
A more recent version of this article appeared on April 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/4/1238    most recent
01.STR.0000260095.94175.d0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, R.
Right arrow Articles by Levine, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, R.
Right arrow Articles by Levine, B. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PHENYLEPHRINE
Related Collections
Right arrow Brain Circulation and Metabolism
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Autonomic, reflex, and neurohumoral control of circulation

Submitted on October 3, 2006
Accepted on November 24, 2006

Autonomic Ganglionic Blockade Does Not Prevent Reduction in Cerebral Blood Flow Velocity During Orthostasis in Humans

Rong Zhang PhD* and Benjamin D. Levine MD

From Institute for Exercise and Environmental Medicine, Presbyterian Hospital of Dallas, Tex; and the University of Texas Southwestern Medical Center at Dallas, Tex.

* To whom correspondence should be addressed. E-mail: rongzhang{at}TexasHealth.org.

Background and Purpose--The underlying mechanisms for reductions in cerebral blood flow (CBF) during orthostasis are not completely understood. This study tested the hypothesis that sympathetic activation causes cerebral vasoconstriction leading to reductions in CBF during lower body negative pressure (LBNP).

Methods--CBF velocity, arterial pressure, and end-tidal CO2 were measured during LBNP (-30 to -50 mm Hg) in 11 healthy subjects before and after autonomic ganglionic blockade with trimethaphan. Arterial partial pressure of CO2 also was measured in a subgroup of 5 subjects. Mean arterial pressure during LBNP after blockade was maintained by infusion of phenylephrine.

Results--Before blockade, mean arterial pressure did not change during LBNP. However, CBF velocity was reduced in all subjects by 14% (P<0.05). Systolic and pulsatile (systolic-diastolic) CBF velocity were reduced by 18% and 28%, respectively, associated with significant reductions in pulse arterial pressure and end-tidal CO2 (all P<0.05). After blockade, mean arterial pressure during LBNP was well-maintained and even increased slightly with infusion of phenylephrine. However, reductions in mean, systolic, and pulsatile CBF velocity, pulse arterial pressure, and ETCO2 were similar to those before blockade. In contrast to reductions in end-tidal CO2, arterial partial pressure of CO2 did not change during LBNP.

Conclusions--These data, contrary to our hypothesis, demonstrate that sympathetic vasoconstriction is not the primary mechanism underlying reductions in CBF during moderate LBNP. We speculate that diminished pulse arterial pressure or pulsatile blood flow may reduce cerebral vessel wall shear stress and contribute to reductions in CBF during orthostasis through flow mediated regulatory mechanisms.


Key words: cerebral hemodynamics • orthostasis • sympathetic nervous system • transcranial Doppler




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
S. Strandgaard and S. T. Sigurdsson
Counterpoint: Sympathetic nerve activity does not influence cerebral blood flow
J Appl Physiol, October 1, 2008; 105(4): 1366 - 1367.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. D. Levine, R. Zhang, M. Visocchi, P. N. Ainslie, S. Ogoh, L. Edvinsson, M. Yildiz, O. B. Paulson, G. M. Knudsen, P. A. Cassaglia, et al.
Comments on Point:Counterpoint: Sympathetic activity does/does not influence cerebral blood flow
J Appl Physiol, October 1, 2008; 105(4): 1369 - 1373.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Strandgaard and S. T. Sigurdsson
Last Word on Point:Counterpoint: Sympathetic nervous activity does/does not influence cerebral blood flow
J Appl Physiol, October 1, 2008; 105(4): 1375 - 1375.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Rebuttal from Strandgaard and Sigurdsson
J Appl Physiol, October 1, 2008; 105(4): 1367 - 1368.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. J. van Lieshout and N. H. Secher
Point:Counterpoint: Sympathetic activity does/does not influence cerebral blood flow
J Appl Physiol, October 1, 2008; 105(4): 1364 - 1366.
[Full Text] [PDF]